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Antisera raised by the injection into sheep of presynaptic plasma membranes isolated fr m the purely cholinergic electromotor nerve 
terminals of Torpedo marmorata recognize a cholinergic-specific epitope, designated Chol-1 which has been shown to be gangliosidic n nature 
both in Torpedo (Richardson et al., 1982) and guinea-pig brain (Ferretti and Borroni, 1986). In rat brain the serum recognizes a group of 
antigenically-related minor gangliosides (Chol-la, fl and 7) which migrate just below the standard gangliosides GQ, GT1B and between GDlb 
and GDla, respectively. We have studied the evelopmental expression of these gangliosides in rat brain and hippocampus and in the 
neuromuscular junction of rat intercostal muscle in an attempt to correlate their expression with specific events in th  development of the 
cholinergic neuron. The period in which Chol-1 is first detected suggests that it is expressed relatively late during the maturation process of 
the cholinergic synapse. This is supported by the finding: (a) that it is not detected in the growth cones (immature nerve terminals) in 5-day-old 
rat brain but is in the whole brain implying that only the more mature nerve terminals present at this stage express Chol-1; and (b) that Chol-1 
is first expressed in the neuromuscular junction at a time in which functional synapses are already present. These results argue against a role 
for the Chol-1 antigens as recognition molecules in the formation of cholinergic synapses. Theexpression of Choi-1 in both the hippocampus 
and the neuromuscular junction correlates well with the establishment of the adult pattern of innervation; thus the Chol-1 antigens may be 
seen as markers for mature cholinergic terminals. 
INTRODUCTION 
There is increasing evidence that carbohydrate anti- 
gens may serve as specific markers for different classes of 
neural cells. Thus galactocerebroside may be used as a 
marker for oligodendrocytes and Schwann cells 21'33 and 
tetanus toxin which binds primarily to the gangliosides 
GDlb  and GTlb,  may be used as a neuron-specific 
probe 33. Furthermore, the expression of carbohydrate 
antigens has been observed to vary within the same cell 
type so that subpopulations of such cell types can be 
identified. Thus Dodd and Jessel 9 have shown that 
complex glycolipids of the globo- and lacto-series specify 
subsets of neurons in the rat dorsal root ganglion and that 
the expression of these antigens on specific dorsal root 
ganglion cells correlates with their functional c assifica- 
tion. 
Previous work in our laboratory has led to the 
identification of a group of antigenically related minor 
gangliosides, collectively designated Chol-1, that appear 
to be exclusively localized on cholinergic neurons in the 
central and peripheral nervous systems 2'12'3~. These 
antigens were detected by the use of an antiserum 
(anti-Chol-1 antiserum) raised against presynaptic plasma 
membranes derived from the purely cholinergic innerva- 
tion of the electric organ of Torpedo marmorata 22'37,47. 
This serum induced a selective complement-mediated 
lysis of the cholinergic subpopulation of mammalian 
brain synaptosomes indicating the expression of this 
antigen on the external surface of mammalian cholinergic 
nerve terminals 2,35. Further support for the cholinergic 
specificity of this antigen came from the following 
findings: (a) anti-Chol-1 antiserum can be used to 
specifically stain cholinergic elements in the rat CNS31; 
(b) section of the fimbria, which causes a massive 
degeneration of cholinergic terminals in the hippocam- 
pus, leads to a concomitant fall in the level of Chol-1 in 
the hippocampusS; (c) the anti-Chol-1 antiserum can be 
used to affinity-purify the cholinergic subpopulation of 
synaptosomes from the total population of rat brain 
synaptosomes 36.
Recently, our interest has focused on the function of 
the Chol-1 gangliosides. Large changes in the concentra- 
tion and distribution of gangliosides and other glycocon- 
jugates have been observed uring differentiation both in 
vitro and in vivo ~8'25, thus implicating them in diverse 
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processes in neural development such as cell adhesion 27, 
neuritogenesis 11'38 and synaptogenesis w'3n. Most of these 
studies, however, have investigated changes in major 
gangliosides. The anti-Chol-1 antiserum provides the 
opportunity of studying minor gangliosidic antigens ex- 
pressed only by cholinergic neurons. Their developmen- 
tal expression may thus provide a marker for cholinergic 
neurons at a specific stage in their development. Fur- 
thermore, temporal correlation of the expression of 
Chol-1 with processes occurring during the maturation of 
the cholinergic system may well guide further investiga- 
tion of their function. 
We have accordingly quantified the developmental 
expression of the Chol-1 antigens in whole rat brain and 
hippocarnpus relative to the expression of the cholinergic- 
specific marker choline acetyl-transferase (CHAT), and 
present an immunohistochemical study of their expres- 
sion in the neuromuscular junction (nmj) of intercostal 
muscle. Both the hippocampus 29 and the neuromuscular 
junction 7 provide systems in which the time course of the 
main events of cholinergic synaptogenesis have already 
been described. 
MATERIALS AND METHODS 
Tissues and subcellular fractions 
Tissue preparation. Postnatal and adult Wistar albino rats were 
obtained from the Institute's breeding colony. Animals were killed 
by decapitation and dissected on ice. Material removed was 
immediately frozen in liquid nitrogen and stored at -80 °C. 
Preparation of growth cones. These were prepared by the method 
of Gordon-Weeks and Lockerbie 16 from 5-day postnatal rat brain 
and were generously donated by Dr G.I. Kristjansson. 
Preparation and treatment of gangliosides 
Sources and chromatography. The polysialoganglioside fraction 
PSG 4 was obtained from Dr Pallmann GmbH (Munich, ER.G.). 
Other gangliosides were prepared according to Tettamanti et al, 46 
and their sialic acid content assayed by the resoreinol method 43. 
Fig. 1. The Chol-1 gangliosides in rat brain Adult rat brain 
gangliosides (lanes 1 and 4), PSG 4 gangliosides tlanes 2 and 5) and 
PSG 4 gangliosides which have been dialysed overnight against 
distilled water (lanes 3 and 6) are shown. Lanes i, 2 and 3 show the 
result of immune staining w thanti-Chol-1 antiserum and lanes 4, 5 
and 6 are lanes 1, 2 and 3 rephotographed after staining with 
Ehrlich's reagent. Chol-la, /3 and 7 can be seen migrating below 
GQ, below GTlb and between GDlb and GDIa respectively. Lane 
3 shows that Chol-ly can be formed by dialysis of a fraction which 
contains only Chol-lct and ft. The relative abundance of the major 
gangliosides in lane 4 is somewhat different from that reported in 
the literature. This is due to the fact that Ehrlich's reagent was
applied after the completion of the immune staining. When 
chromatograms not previously submitted to immune staining were 
treated with Ehrlich's reagent a standard patte nwas obtained 
(compare the pattern in lane 4 with that of lane 5 in Fig. 4). 
Since further purification of the gangliosides by means of DEAE, 
Kieselgel and other chromatographic procedures do notalter the 
immunoreactivity of our antiserum toward the Chol-I bands we 
have not further purified the ganglioside fractions used in this study. 
Fig. 2. Protease insensitivity of the Chol-1 gangliosides. The PSG 4 ganglioside fraction is shown separated on TLC following treatment with
protease type VI (lanes 2 and 6), protease type V (lanes 3 and 7), trypsin (lanes 4 and 8) and control (lanes 1 and 5). Lanes 1-4 are the results 
of immune staining with anti-Chol-1 antiserum and lanes 5-8 are those of staining with Ehrlich's reagent using the same procedure as Fig. 
1. Protease treatment has no apparent effect on the Chol-1 gangliosides since there is no significant change in immunoreactivity and in the 
chromatographic mobility of he gangliosides on the TLC. In all cases a and fl can be seen migrating just below GTlb and GQ. 
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Ganglioside molecular species containing between 2 and 5 /~g 
sialic acid were separated by thin-layer chromatography (TLC) on 
Kieselgel 60 high performance TLC (HPTLC) plates (Merck, 
Darmstadt, ER.G.) at 22 °C using chloroform/methanol/0.2% 
CaCl 2 (40:42:11). Gangliosides were rendered visible, often after 
immune staining (see below), by spraying with p-dimethylamino- 
benzaldehyde (Ehrlich's reagent), followed by heating at 140 °C for 
15 min a2. The plates were calibrated with bovine standard ganglio- 
sides (Seromed, Munich, ER.G.). The nomenclature of ganglio- 
sides is that of Svennerholm 44:5. 
Neuraminidase digestion. Gangliosides extracted from rat brain 
were dissolved in 1 mM acetate buffer, pH 5, containing 1 unit of 
neuraminidase (type V: purified from Clostridium perfringens, 
Sigma, Munich, ER.G.) per 50/~g of ganglioside-bound sialic acid 
and incubated at 37 °C for 12 h. A further 0.5 units of neuramini- 
dase in the same buffer was added and the reaction mixture 
incubated for a further 6 h at 37 °C. 
The mixture was then dialysed against 50 ml of double-distilled 
water on a Millipore VSWP 013 filter (porosity 0.05/~m) for 5 min, 
the residue was collected, lyophilized, resuspended in chloroform/ 
methanol (2:1 v/v) and centrifuged in an Eppendorf table-top 
centrifuge to remove any debris. The solvent containing the 
gangliosides was stored at -25 °C. 
Protease treatment.Protease typ  V and type VI from Strep- 
tomyces griseus (Sigma, Munich, ER.G.) were incubated with 200 
/~g PSG 4 at a concentration of 1 unit per 100/~g ganglioside (dry 
weight) for 60 min at 37 °C in Tris-buffered saline (pH 7.9). Trypsin 
from bovine pancreas (Sigma, Munich, ER.G.) was incubated with 
200/.tg PSG 4 (1/~g/50/~g) overnight at 37 °C in Tris-buffered saline 
(pH 8.0). The above were then dialysed against 100 ml of 
double-distilled water on a Millipore VSWP 013 filter (porosity 0.05 
/zm) for 5 min, the residue collected, lyophilized, resuspended in
chloroform/methanol (2:1 v/v) and centrifuged in an Eppendorf 
table top centrifuge to remove any debris. The solvent containing 
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Fig. 3. Neuraminidase nsitivity of the Chol-1 gangliosides. PSG 4 
gangliosides, with (lanes 2 and 4) and without (lanes 1 and 3) 
neuraminidase treatment are shown. Lanes 1 and 2 are immune 
stained with anti-Chol-1 antiserum and lanes 3 and 4 are lanes I and 
2 after staining with Ehrlich's reagent. Neuraminidase treatment in 
the conditions described in 'Materials and Methods' will remove all 
sialic acid residues not bound directly to the oligosaccharide 
backbone of gangliosides; the effectiveness of this treatment can be 
seen by the change in migration of the Ehrlich-positive bands in 
PSG 4 from polysialogangliosides to GM1 and much more faintly 
above it GM2. Following such neuraminidase treatment immuno- 
reactivity against Chol-1 is lost. This indicates the presence of sialic 
acid in Chol-1. Note also that a higher amount of gangliosides was 
loaded on lane 4. 
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Fig. 4. The developmental expression of Chol-1 in rat brain. A: 
gangliosides prepared from 5, 10, 20 and 30 day and adult brain 
containing 5, 5, 4, 3 and 3/~g sialic acid, respectively were separated 
on TLC and immune stained with anti-Chol-1 antiserum (lanes 1-5). 
The expression of the immunoreactive Chol-1 gangliosides relative 
to the total ganglioside mixture can be seen to increase during 
development with Chol-la, fl and y being first detected 5, 10 and 
20 days postnatal, respectively. Different amounts of gangliosides 
were loaded in each lane so that the intensity of the immune staining 
on the TLC would be within the limits of the linearity of the system. 
Various concentrations of PSG 4 were run on the same TLC to 
check the linearity of the immune response and to enable the 
quantification of Chol-1 by densitometric s anning. B: gangliosides 
extracted from brains of the same developmental stages were 
separated on TLC (3 ag of sialic acid per lane) and stained with 
Ehrlich's reagent (lanes 1-5, respectively). The band labelled by the 
asterisk is a contaminant of the preparation since it is stained yellow 
by Ehrlich's reagent. Arrowheads indicate the positions of standard 
gangliosides - from the top: GM1, GDla, GDlb, GTlb and GQ. 
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lmmunochemical methods 
Affinity purificaton of serum. Anti-Chol-1 antiserum was that 
described by Richardson et al. 37 and affinity purified as described by 
Ferretti and Borroni ~=. The affinity purification of the anti-Chol-1 
antiserum is based on the observation that gangliosides extracted 
from the electric organ of Torpedo marmorata provide a richer 
source of antigen than mammalian brain gangliosides. Affinity 
purification of the antiserum on immobilized Torpedo electric organ 
gangliosides greatly increases its capacity to induce lysis of the 
cholinergic synaptosomes and renders it specific for the Chol-1 
antigen ~2. Briefly, Torpedo electric organ gangliosides containing 5
mg of ganglioside-bound sialic acid were covalently bound to 
long-chain alkylamine, controlled pore, glass beads (Pierce Chem- 
icals, Rockford, U.S.A.) according to Young et al. 48. The column 
was washed with 5 ml of 10 mM sodium phosphate buffer (pH 7.4) 
in 0.15 M NaC1 (PBS), 3 ml of KSCN and then 8 ml of PBS; 100 
ktl of anti-Chol-1 antiserum were passed through the column 5 times 
and after extensive washing with PBS the bound antibodies were 
eluted with 1 ml of 3 M KSCN and 2 ml of PBS. The eluate was 
dialysed in the presence of BSA against PBS and stored in aliquots 
at -20 °C. 
Immune staining on TLC. Detection of antigenic gangliosides 
separated on aluminium-backed TLC (as described) was performed 
by a modification of the method of Brockaus et al. 4. A peroxidase- 
labelled rabbit anti-sheep Ig (Cappel Laboratories, Dinatech, 
Plochingen, ER.G.)  was used to detect the anti-Chol-1 antiserum 
bound to gangliosides. The reaction was developed by dipping the 
chromatogram in 0.01% 4-dichloro-l-naphthol and 0.9 mM H20 = in 
PBS. 
Quantification was performed using a Shimadzu C5-930 dual 
wave-length TLC scanner with a Shimadzu D2-2 data recorder. The 
limits of linearity of the immune response were established using the 
PSG 4 fraction which was found to be highly enriched with respect 
to Chol-18. Usually immune staining was followed by spraying the 
TLC with Ehrlich's reagent. Though the presence of the immuno- 
chemical reagents somewhat distorted the relative abundance of the 
various gangliosides this method was preferred in some experiments 
since it allowed a direct comparison of the chromatographic 
mobilities of the immunoreactive bands with those of the major 
gangliosides. 
lmmunohistochemistry. Unfixed cryostat scctit~m, ~t rat intcrcos 
tal muscle were fixed in acetone for 10 min at -20 °(" and after air 
drying were stained by conventional immunofluorescence tcch. 
niques. Briefly, sections were incubated for 30 rain in 1% BSA, 10% 
rabbit non-immune serum in PBS (PBSA), incubated 2 h in 
affinity-purified antibody diluted 3-fold in PBSA, washed 6 times for 
5 min in PBS, then incubated 1 h with fluorescein isothiocyanate- 
conjugated rabbit anti-sheep IgG diluted I:I[X) in PBSA and 
tz-bungarotoxin (obtained from Boehringer, Mannheim. F.R.G.) 
diluted 1:20 in the same medium and labelled with tetramethyl 
rhodamine isothiocyanate according to the method o| Ravdin and 
Axelrod 34. Prior to use the second antibody was adsorbed against 
rat diaphragm membranes. The amount of IgG in the affinity- 
purified anti-Chol-1 antiserum was determined to be 30-50 #g/ml, 
therefore an equivalent amount of IgG prepared from non-immune 
sheep serum was used as a control. A section treated with 
a-bungarotoxin a d non-immune sheep serum was included for each 
stage. This was done in order to control: (a) that the signal due to 
ct-bungarotoxin will not contribute to the Chol-1 immunoreactivity 
by passing through the fluorescein filter; and (b) the level of 
background staining due to non-specific binding. 
Other assays. Whole rat brains and hippocampi were homog- 
enized in PBS and diluted to a concentration of 1:100 (w/v) in PBS. 
Samples (50 #1) of this homogenate were assayed for ChAT 
according to Fonnum ~5. Their protein content was estimated 
according to Lowry z6 
RESULTS 
The Chol-1 antigen 
It has previously been shown that the cholinergic- 
specific antigenic determinant recognized by the anti, 
Chol-1 antiserum in guinea-pig brain is located on two 
gangliosides migrating on TLC just below GQ and 
GTlb t2. However, since the present study was carried 
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Fig. 5. A: the quantitative developmental expression of CHAT, Chol-1 and ganglioside-bound sialic acid in rat brain. Data are calculated per 
unit of wet weight and expressed as percentages of adult values. Circles, ganglioside-bound sialic acid; diamonds. CHAT; asterisks, Chol-1. 
For Chol-1 and CHAT, each point represents he mean + S.D. of 3 experiments; for sialic acid, the results of a typical experiment are shown. 
The expression of Chol-1 correlates very closely with that of ChAT during development though the latter eaches a plateau several days earlier. 
B: developmental expression of Chol-1 and major brain gangliosides. Equal amounts of ganglioside (5/~g sialic acid) prepared from the various 
developmental stages were separated on TLC and stained with Ehrlich's reagent or immune-stained with anti-Chol-1 antiserum. The major 
brain gangliosides were quantified by densitometric s anning, calculated as molar concentrations and plotted as percentages of adult value. 
Chol-1 values (asterisks) were calculated as units per 5/~g sialic acid and plotted as percentages of adult values. The developmental pattern 
of the major ganglioside is in agreement with that of previous reports 2s'42. Empty triangles, GMI: empty squares. GDla:  filled squares, GDlb:  
filled circles, GTlb. 
the presence of these antigenic components in this 
animal. 
In rat brain the anti-Chol-1 antiserum recognized three 
minor glycolipids, two migrating on TLC below GQ and 
GTlb  (identical with those found in guinea pig) and a 
third, fainter component between GDlb  and GDla.  
These will be referred to as Chol-la, fl and y, respectively 
(Fig. 1). We strongly suspect, however, that Chol-ly may 
be an artefactual component produced by the breakdown 
of either Chol- la or fl (or both). Fig. 1 shows ganglio- 
sides extracted from adult rat brain separated on TLC 
and stained with anti-Chol-1 antiserum followed by 
Ehrlich's reagent (lanes 1 and 4). A polysialoganglioside 
fraction (PSG 4) which we have found to be enriched 
with respect o the Chol- la and fl antigens is also shown 
(lanes 2 and 5). We have found that by simply dialysing 
the PSG 4 ganglioside fraction against distilled water 
overnight one can induce the formation of Chol-17 (lanes 
3 and 6). The reasons for this apparent sensitivity to 
dialysis are presently unclear. Experiments are in 
progress to clarify this point. 
Amphiphilic glycoproteins and glycopeptides are 
known to copurify with gangliosides and migrate on TLC 
in a similar manner. In order to show that the Chol-1 
antigens are not peptidic ontaminants of our ganglioside 
preparations we have tested their sensitivity to protease 
digestion. Fig. 2 shows the PSG 4 ganglioside fraction 
following treatment by protease type VI (lanes 2 and 6), 
protease type V (lanes 3 and 7) and trypsin (lanes 4 and 
8). Comparison with control PSG 4 (lanes 1 and 5) shows 
that there is no significant change of immune reactivity 
following each of these treatments. Furthermore we have 
applied varying amounts of the PSG 4 gangliosides to 
polyacrylamide gels and stained them with the highly 
sensitive silver staining procedure. No bands were de- 
tected (results not shown). These results argue strongly 
against he Chol-1 antigens' being peptidic contaminants 
of the ganglioside preparations. 
Non-gangliosidic acidic glycolipids are also known to 
contaminate ganglioside preparations. Therefore in order 
to demonstrate the presence of sialic acid in the Chol-1 
antigens and hence to confirm their gangliosidic nature 
we have carried out neuraminidase treatment of the PSG 
4 ganglioside fraction. When the PSG 4 ganglioside 
fraction was digested with neuraminidase in conditions 
such that all the major gangliosides are metabolized to 
GM1, immunoreactivity against the Chol-1 antigens is 
lost (Fig. 3). In conditions where the digestion is less 
complete immunoreactive bands migrating with higher 
RF's can be seen 8. These results demonstrate the 
presence of sialic acid in the Chol-1 antigens. Together 
with the evidence presented earlier 12 these data provide 
evidence in favour of the gangliosidic nature of Chol-1. 
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In other work (Giuliani et al., submitted for publication) 
we have purified Chol-lfl 4000 times and all the proper- 
ties of the purified antigen are in agreement with its being 
gangliosidic in nature. 
Developmental expression of Chol-1 in rat brain 
Gangliosides extracted from the brains of both embry- 
onic and postnatal animals containing between 3 and 5/~g 
X 
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Fig. 6. The developmental expression of Chol-1 in rat hippocampus. 
A: gangliosides prepared from 5, 10, 20 and 30 day and adult 
hippocampus containing 5, 5, 4, 3 and 3 gg sialic acid, respectively 
were separated on TLC and stained with anti-Chol-I antiserum 
(lanes 1-5). The expression of the immunoreactive Chol-1 ganglio- 
sides can be seen to increase relative to the total gangliosides during 
development, Chol-la and fl first being detected 10 days postnatally 
and Chol-1), 20 days postnatally. Different amounts of gangliosides 
were loaded in each lane so that the intensity of the immune staining 
would be within the limits of the linearity of the system (see also 
legend to Fig. 4). B: gangliosides prepared from hippocampi f the 
same developmental series were separated on TLC (3 gg sialic acid 
per lane) and stained with Ehrlich's reagent (lane 1-5, respectively). 
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Fig. 7. A: the quantitative developmental expression of CHAT, Chol-1 and ganglioside-bound sialic acid in rat h ppocampus. The expression 
of Chol-1 can be seen to increase in parallel with that of ChAT though it appears to lag behind the expression of ChAT by about 20 days: 
Data were calculated per unit of wet weight and expressed as percentages of adult values. Circles, ganglioside-bound siatic acid; asterisks, 
Chol-1; diamonds, CHAT. For Chol-1 and CHAT, each point represents he mean + S.D. of 3 experiments; for sialic acid, the results of a typical 
experiment are shown. B: developmental expression of Chol-1 and major gangliosides. Data were calculated and expressed as indicated in the 
legend of Fig. 5B. Asterisks, Chol-1; empty triangles, GM1; empty squares, GDla; filled squares, GDlb; filled circles, GTlb. 
sialic acid were immune stained on TLC as described in 
the 'Materials and Methods'. Chol-1 a, fl and 7 were first 
detected at 5, 10 and 20 days postnatally, respectively 
(Fig. 4). Since ChAT is the enzyme responsible for the 
synthesis of acetylcholine we have used its expression as 
an index of cholinergic synaptogenesis. Quantitation of 
both ChAT and Chol-1 during development shows that 
the level of Choi-1 closely follows that of ChAT (Fig. 
5A). Though the major gangiiosides are also increasing in 
concentration during this period 28'42 as shown by the 
increase in ganglioside-bound sialic acid per unit of 
weight (Fig. 5A), it should be noted that they have 
already reached approximately 50% of their adult levels 
by postnatal day 5. Chol-1 at this stage is only 8% of its 
adult level and it rises rapidly during the next 50 days in 
a manner closely correlated with the rise of CHAT. In Fig. 
5B, the pattern of expression of Chol-1 is compared with 
that of the major brain gangliosides. Data are expressed 
here as the relative concentration per unit of ganglioside- 
bound sialic acid. Within the ganglioside pool, the rate of 
increase during this period in the concentration of Chol-1 
is considerably higher than that of GM1 and GDlb  while 
the relative concentrations of GT lb  and GDla  fall. 
The close correlation between the expression of Chol-1 
and ChAT combined with its general period of expression 
in the brain suggests that Chol-1 may be involved in 
processes related to the formation and/or maturation of 
cholinergic nerve terminals. In order to establish whether 
or not Chol-1 was expressed by the presynaptic plasma 
membrane before synaptogenesis, gangliosides were ex- 
tracted from growth cone particles isolated from 5-day 
postnatal rat brain. Five micrograms of ganglioside- 
bound sialic acid prepared from growth cones and 
5-day-old brain were loaded on TLC and immune stained 
with anti-Chol-1 antiserum. Chol-1 was not detected in 
growth cones (result not shown); however, since it is 
detected in the whole brain at this time in development, 
Chol-1 is probably located in the more mature cholinergic 
synapses. 
In order to establish with greater resolution at which 
stage Chol-1 is expressed uring synaptogenesis we have 
studied its expression in two systems in which the major 
events of cholinergic synaptogenesis have been thor- 
oughly described. 
The developmental expression of Chol-1 in the hippocam- 
pus of rat 
Though the cell bodies of cholinergic interneurons 
have been found in the hippocamplts 23 lesions of the 
fimbria demonstrate that the vast majority of the cho- 
linergic innervation of the hippocampus originates from 
cell bodies in the basal forebrain 1. Since such lesions 
Fig. 8. Developmental expression of Chol-1 in the rat neuromuscular junction. Sections take  from 3- (A, B), 10-day-old :(C, D) and adult 
(E-H) rat intercostal muscle were double-stained with rhodamine-labeUed a-bungarotoxin (A, C, E and G) and with affinity-purified 
anti-Chol-1 antiserum (B, D andF) or sheep non-immune serum (H). The bound antibodies were visualized using~ flu0re~in,conj~ted 
second antibody. Chol-1 immunoreactivity is first detected atpostnatal day 3. The staining intensity a  this stage is low but deafly distinguishable 
from that of the non-immune serum. The intensity of the staining increases during development as shown bythe 10-day and adult sections, 
The co-localization between a-bungarotoxin (which binds specifically to the n otinic acetylcholine receptor) and the antigen(s) recog~zed by 
anti-Choi-1 antiserum confirms the localization of the Chol-1 immunoreactivity a  the level of the neuromuscular junction. O ly very faint, 
non-specific staining, mainly distributed on the connective tissue thatsurrounds the muscle bundles, was observed using control heep serum 
(H). Bars = 10/am. 
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result in an approximately 90% loss of ChAT in the 
ipsilateral hippocampus one may conclude that no more 
than 10% of the cholinergic innervation of the hippo- 
campus is due to endogenous interneurons. Thus the 
change in the level of cholinergic markers, including 
Chol-1, in the hippocampus during development will 
primarily reflect cholinergic synaptogenesis rather than 
other processes. 
Gangliosides from the hippocampi of rats, ages ranging 
from 5 to 50 days postnatal, and from adult rat hippo- 
campus were separated on TLC and immune stained. 
Chol-la and fl were first detected at postnatal day 10 and 
Chol-ly at day 20 (Fig. 6). The quantitation of ChAT and 
Chol-1 during development (Fig. 7A) shows that there is 
a close correlation between these two markers. The 
expression of Chol-1 lags behind that of ChAT suggesting 
that it is expressed by the cholinergic terminals later. The 
comparison of the pattern of expression of Chol-1 with 
that of the major gangliosides confirms the results 
obtained in total brain. Chol-1 rises rapidly to almost he 
adult level during the first 50 days of life. In the same 
period the relative concentrations of GM1 and GDlb 
show smaller increases while those of GDla  and GTlb 
fall (Fig. 7B). 
Developmental expression of Chol-1 at the neuromuscular 
junction of the intercostal muscle 
Chol-1 can first be detected at the neuromuscular 
junction colocalizing with a-bungarotoxin (a highly spe- 
cific label for the acetylcholine r ceptor) at postnatal day 
3 (Fig. 8). Though the staining intensity at this stage is 
low it can be seen to increase during development as 
shown by the 10 day and adult sections. 
DISCUSSION 
Previous work done in this laboratory has shown that 
the anti-Chol-1 antiserum recognizes minor gangliosides 
located selectively on the cell surface of cholinergic 
neurons. The expression of these gangliosides appears to 
be developmentally regulated. They are first detected in 
rat brain, respectively at 5, 10 and 20 days postnatally. 
Their level of expression closely follows that of the 
cholinergic marker CHAT. Because Chol-1 first appears 
in the period during which synaptogenesis is taking place, 
as measured by the expression of several nerve terminal 
related markers e.g. synaptophysin ~4, acetyleholinester- 
ase (ACHE) 13 and ChAT (this paper, Fig. 5), we have 
studied the expression of Chol-1 in two systems within 
which the development of cholinergic synapses has been 
well characterized: the neuromuscular junction of the 
intercostal muscle and the hippocampus of rat. 
Complete section of the fornix fimbria interrupts the 
septohippocampal fibre tract and causes the degeneration 
of about 90% of the cholinergic system ol the hippocam- 
pus, as measured by the fall in the level of ChAT ~°. It has 
also been established that concomitant falls in the level of 
Chol-1 are caused by such lesions 8. Thus changes in the 
levels of cholinergic markers in the hippocampus during 
development will primarily reflect cholinergic synapto- 
genesis rather than any other process occurring in the 
cholinergic neurons at this time. Orthograde and retro- 
grade labelling experiments have shown that fibres from 
the cholinergic cell bodies of the medial septum first 
begin innervating the hippocampus as early as foetal day 
1629 . Though the distribution of terminals is at first 
diffuse, between postnatal days 3 and 14 hippocampal 
regions which are most innervated in the adult animals 
become progressively more innervated and terminals in 
areas which do not exhibit cholinergic innervation in 
adults are progressively eliminated 29. It is interesting to 
note, however, that the presence of cholinergic markers 
such as CHAT, AChE and high affinity choline uptake do 
not appear until postnatal days 1, 4 and 6 after the 
cholinergic fibres enter the hippocampus respectively 29,
Chol-1 is first detected 10 days postnatal. It increases 
rapidly in concentration during the next 30 days paral- 
leling the increase shown by ChAT though lagging behind 
by about 20 days. This strongly suggests that the 
expression of Chol-1 is a membrane modification very 
late in the development of the cholinergic synapse. This 
is consistent with the finding that Chol-1 is not found in 
the growth cone particles (immature nerve terminals) in 
5-day old brain but is found in the whole brain at this 
time, suggesting that Chol-1 is present only in the more 
mature cholinergic elements at this time. 
Further support for this conclusion came from the 
finding that Choi-1 is first detected in the neuromuscular 
junction three days postnatally. At this time the synapses 
in the intercostal muscle have already formed and are 
electrophysiologically functional v.Thus the expression of 
Chol-1 is an occurrence late in the maturation of the 
cholinergic synapse both in the central and the peripheral 
nervous ystem of the rat. Similar results were obtained 
in a study of the developmental expression of Chol-I in 
the electric organ of Torpedo marmorata 14. 
Gangliosides have been implicated in a great variety of 
processes related to the development of the nervous 
system e.g. as stimulators of neurite outgrowth 5'11, as 
recognition molecules and adhesion molecules 6'2v, as 
modulators of cell growth 41 and in cell motility 39, The late 
onset of expression of Chol-1 would seem to rule out the 
possibility that it is involved in cell motility or that it 
functions as a recognition molecule during synaptogen- 
esis. 
However, there is increasing evidence that gangliosides 
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are effective in modulating receptors for various trophic 
factors and proteins. Anti-ganglioside antibodies inhibit 
nerve growth factor induced sprouting from chick dorsal 
root ganglia 4°. Gangliosides appear to modulate the 
receptor for platelet derived growth factor 3, epidermal 
growth factor 19 and ganglioside GD2 has been shown to 
modulate the affinity of a melanoma receptor for the 
extracellular matrix protein vitronectin by associating 
with the receptor in a calcium dependent manner 6. 
Interestingly, Chol-1 is first being expressed in the 
hippocampus during the period in which the action of 
nerve growth factor on septal neurons innervating the 
hippocampus changes from inducing the production of 
ChAT to promotion of cell survival 2°. In the neuromus- 
cular junction Chol-1 is first detected uring the period 
when the multiple innervation of muscle fibres is being 
el iminated 7. We are currently trying to establish whether 
this correlation between the expression of the Chol-1 
gangliosides and the stablishment of the adult pattern of 
the cholinergic innervation of the hippocampus and the 
neuromuscular junction is not merely coincidental. Thus 
we are investigating whether Chol-1 might be expressed 
either to modulate the nerve growth factor receptor in 
the hippocampus or a putative cell adhesion complex 
which is acting to stabilize cholinergic synapses. 
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